Join the Roquette team on stand 80C90 (Excipient Gold area) at CPHI in Frankfurt, Germany, to discover the latest innovations in direct compression technology, designed to overcome unique drug formulation challenges and support expansion into novel application areas.
Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
Following its purchase of a majority share in the company in 2018, this latest move allows Roquette to continue realizing its strong growth ambitions and meet rising global demand for high-quality plant-based excipients.
Roquette expands PEARLITOL® SD mannitol range for highly sensitive active pharmaceutical ingredients (APIs)
Developed specifically for active pharmaceutical ingredients (APIs) that are highly sensitive to reducing sugars, PEARLITOL® 150 SD supports opportunities to unlock advanced tablet dosage forms – even when using challenging active ingredients.